March 11, 2014Open Access

Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

Key points are not available for this paper at this time.

Clinicaltrials.gov NCT00356460.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Morris et al. (Tue,) studied this question.

John C. Morris

Antoinette R. Tan

Thomas Olencki

SHILAP Revista de lepidopterología

PLoS ONE

Massachusetts General Hospital

Dana-Farber Cancer Institute

The Ohio State University

Building similarity graph...

Analyzing shared references across papers